The results of this “Molnupiravir is also being studied in a Phase III trial for preventing infection in people exposed to the coronavirus.” will even be more interesting.

News+
1

The results of this “Molnupiravir is also being studied in a Phase III trial for preventing infection in people exposed to the coronavirus.” will even be more interesting.
Positive outcomes will dramatically reduce the need for COVID vaccines.